Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 23,005-23,016 of 23,847
Drug study icon
CompletedNCT02618408

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Rogers
ADHDDrugA study involving a medication or substance.From 6 Years to 12 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
Drug study icon
CompletedNCT02618434

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Chandler
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
Drug study icon
CompletedNCT00183443

Treatment of Mania Symptoms With Drug Therapy

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

In Palo Alto
Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Palo Alto Veterans Institute for Research
Condition
Bipolarity, Schizophrenia
Device study icon
CompletedNCT02204787

Treatment of Negative Symptoms and Schizophrenia

This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

In Montpellier
SchizophreniaDeviceFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.